SPG20 anticorps (N-Term)
Aperçu rapide pour SPG20 anticorps (N-Term) (ABIN2365481)
Antigène
Voir toutes SPG20 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- SPG20, NT (Spastic Paraplegia 20 Protein, Trans-activated By Hepatitis C Virus Core Protein 1, Spartin, TAHCCP1, KIAA0610)
-
Purification
- Purified by immunoaffinity chromatography.
-
Immunogène
- Synthetic peptide selected from the N-terminal region of human SPG20 (KLH).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))
-
Autre désignation
- SPG20
-
NCBI Accession
- NP_055902
-
UniProt
- Q8N0X7
-
Pathways
- Regulation of Cell Size, SARS-CoV-2 Protein Interactome
Antigène
-